Xu A - Search Results

1

Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study.

Li B, Xu A, Wang N, Min X, Feng Z, Deng M, Li L, Cai J, Kang Z, Jiang K, Kuang D, Wang L. Li B, et al. Among authors: xu a. J Magn Reson Imaging. 2017 Oct;46(4):1220-1229. doi: 10.1002/jmri.25654. Epub 2017 Feb 9. J Magn Reson Imaging. 2017. PMID: 28182304

2

Application of lobaplatin in trans-catheter arterial chemoembolization for primary hepatic carcinoma.

Wang N, Lv YZ, Xu AH, Huang YR, Peng L, Li JR. Wang N, et al. Asian Pac J Cancer Prev. 2014;15(2):647-50. doi: 10.7314/apjcp.2014.15.2.647. Asian Pac J Cancer Prev. 2014. PMID: 24568472 Free article. Clinical Trial.

3

Digital subtract angiography and lipiodol deposits following embolization in cirrhotic nodules of LIRADS category ≥3.

Kang Z, Wang N, Xu A, Wang L. Kang Z, et al. Among authors: xu a. Eur J Radiol Open. 2019 Feb 23;6:106-112. doi: 10.1016/j.ejro.2019.02.005. eCollection 2019. Eur J Radiol Open. 2019. PMID: 30899770 Free PMC article.

4

Retrospective study of TACE in the treatment of lobaplatin-induced thrombocytopenia in primary hepatocellular carcinoma.

Lv Y, Xu A, Wang N, Mu K, Wang Z, Zhao L, Huang Y, Peng L, Xiang K, Hu D, Qi J. Lv Y, et al. Among authors: xu a. J BUON. 2019 Nov-Dec;24(6):2385-2393. J BUON. 2019. PMID: 31983110 Free article.

5

Oxygen-Challenge Blood Oxygen Level-Dependent Magnetic Resonance Imaging for Evaluation of Early Change of Hepatocellular Carcinoma to Chemoembolization: A Feasibility Study.

Li B, Xu A, Huang Y, Peng L, Xiang K, Li Q, Tang D, You H, Tan F, Wang N. Li B, et al. Among authors: xu a. Acad Radiol. 2021 Nov;28 Suppl 1:S13-S19. doi: 10.1016/j.acra.2020.06.021. Epub 2020 Jul 31. Acad Radiol. 2021. PMID: 32747180

6

Predictive role of T2WI and ADC-derived texture parameters in differentiating Gleason score 3 + 4 and 4 + 3 prostate cancer.

Kang Z, Xu A, Wang L. Kang Z, et al. Among authors: xu a. J Xray Sci Technol. 2021;29(2):307-315. doi: 10.3233/XST-200785. J Xray Sci Technol. 2021. PMID: 33522997

7

Apparent Diffusion Coefficient as a Noninvasive Biomarker for the Early Response in Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Using Drug-eluting Beads.

Li B, Zhou L, Xu A, Li Q, Xiang H, Huang Y, Peng L, Xiang K, Zhang M, Wang N. Li B, et al. Among authors: xu a. Curr Med Imaging. 2022;18(11):1186-1194. doi: 10.2174/1573405618666220304141632. Curr Med Imaging. 2022. PMID: 35249499

8

A Randomized Comparison of Transradial and Transfemoral Approach in Hepatic Arterial Infusion Chemotherapy.

Li B, Li Q, Peng L, Xiang K, Xu A. Li B, et al. Among authors: xu a. Curr Med Imaging. 2023 May 11. doi: 10.2174/1573405620666230511094840. Online ahead of print. Curr Med Imaging. 2023. PMID: 37165679

9

Neoadjuvant drug-eluting bead transarterial chemoembolization and tislelizumab therapy for resectable or borderline resectable hepatocellular carcinoma: A propensity score matching analysis.

Zhao J, Wang J, Lu Y, Wu Y, Kuang D, Wang Y, Luo H, Xu A, Zhang W. Zhao J, et al. Among authors: xu a. Eur J Surg Oncol. 2023 Dec;49(12):107106. doi: 10.1016/j.ejso.2023.107106. Epub 2023 Sep 30. Eur J Surg Oncol. 2023. PMID: 37812981 Free article.

10

MRI characteristics and transverse relaxation time measurements in normal growing cartilage.

Li X, Wang R, Li Y, Tang L, Xu A, Hu J. Li X, et al. Among authors: xu a. J Huazhong Univ Sci Technolog Med Sci. 2004;24(4):411-3. doi: 10.1007/BF02861881. J Huazhong Univ Sci Technolog Med Sci. 2004. PMID: 15587412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,909 results

Search Page

Filters